Responses
Original article
Gastrin releasing peptide and gastrin releasing peptide receptor expression in gastrointestinal carcinoid tumours
Compose a Response to This Article
Other responses
Jump to comment:
- Published on: 1 March 2004
- Published on: 1 March 2004The bombesin/GRP antagonist RC-3095 in a patient with the Zollinger-Ellison syndromeShow More
Dear Editor
We read with interest the article by Scott and cols. in the February, 2004 issue of JCP, in which the expression of gastrin-releasing peptide and gastrin-releasing peptide receptors in gastrointestinal carcinoid tumors is discussed.[1]
Currently, we are completing a Phase I trial with the new synthetic bombesin/gastrin-releasing peptide antagonist RC-3095 in patients with advanced refractory solid m...
Conflict of Interest:
None declared.